Markets & Regulations

Cambridge Major expands

Cambridge Major expands

Cambridge Major Laboratories expects to complete construction of a
new process R&D and manufacturing facility in the middle of
2004 that will make it one of the largest Good Manufacturing
Practice (GMP) development and small-scale...

MOCON expands into Europe

MOCON expands into Europe

Instrumentation company MOCON has unveiled plans to acquire
Germany's Paul Lippke Handels, which markets process and laboratory
test systems to companies in the pharmaceutical, food and packaging
industries.

Biotech blasts back in 2003

Biotech blasts back in 2003

2003 was the second best year of all time for the biotechnology
industry, and 2004 looks set to be even better. This is the verdict
of James Burrill, head of US merchant bank Burrill & Co, who
describes the industry as "rising...

Tough times at MeadWestvaco

Tough times at MeadWestvaco

US packaging giant MeadWestvaco has started the second phase of a
restructuring programme aimed at improving productivity at the firm
and boosting both earnings and cash flow, at the cost of 1,000 job
cuts and a number of facility...

Merck refocuses

Merck refocuses

The restructuring activity that has features this year in the
European pharmachem industry continued yesterday with the news that
Germany's Merck KGaA had sold off BioMer, a joint venture focusing
on orthopaedic products.

CMO readies for business

CMO readies for business

US contract manufacturing start-up Xcellerex has completed its
first round of private financing that will enable it to kit out its
recently acquired manufacturing facility in Marlborough,
Massachusetts.

Major contract lifts Lonza

Major contract lifts Lonza

Switzerland's Lonza has won a long-term manufacturing contract from
US biotechnology bellwether Genentech for Rituxan (rituximab) a
biological drug which recorded worldwide sales of $1.48 billion in
2002.

Whatman sells filter business

Whatman sells filter business

UK-headquartered separations company Whatman is to sell its filter
cartridge business to Graver Technologies of the US for $2.1
million (€1.7m) in cash, continuing a string of divestments as it
copes with a decline in revenues.

NanoSystems sticks with Elan

NanoSystems sticks with Elan

Ireland's Elan has said that its US-based drug delivery business,
NanoSystems, will not be part of the sell-off in assets forced by
its onerous debt burden. The company is also retaining its US acute
care products business.

Sad demise of PPL

Sad demise of PPL

Scotland's PPL Therapeutics, once one of the brightest stars in the
UK biotechnology universe, came to desultory end this week when the
company auctioned off most of its remaining assets for just
£169,000 (€242,000).

Follow us

Products

View more

Webinars